ARIS HiQ Instrument
26-007626 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in MD, with responses due 2026-09-03. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The National Institute of Health (NIH) intends to negotiate and award a purchase order without providing for full and open competition to REMEL, INC. The purpose of this requirement is to provide a firm-fixed-price contract for the Remel ARIS HiQ Instrument and associated SWIN Computer System in the
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| CEPHEID | $306K | n/a | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
| ROCHE DIAGNOSTICS CORPORATION | $615K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
Questions
What is solicitation 26-007626?
ARIS HiQ Instrument, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in MD. Responses are due 2026-09-03.
What do similar contracts close for?
Comparable closed awards in this category ran from $64K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is 26-007626 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.